Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ASENSUS SURGICAL, INC.TRXC · Entity 88098 | Director · President and CEO | May 14, 2019 | May 15, 2019 |
| Humacyte, Inc.HUMA · Entity 6478 | Director | June 12, 2025 | June 16, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ASENSUS SURGICAL, INC.
Report date May 14, 2019 · Filed May 15, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 924,359 |
Reported balance
After 2019-05-14 transaction · row 1
1 source rowRow 1 · 2019-05-14 · Exercise / conversion · Acquired 71,943 · Balance 924,359 |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $1.39 · Expires 2028-02-07 | Direct | 928,057 |
Reported balance
After 2019-05-14 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2019-05-14 · Exercise / conversion · Disposed 71,943 · Balance 928,057 |
Humacyte, Inc.
Report date June 12, 2025 · Filed June 16, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.41 · Expires 2035-06-12 | Direct | 80,000 |
Reported balance
After 2025-06-12 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2025-06-12 · Grant · Acquired 80,000 · Balance 80,000 F1: The first 25% of the option becomes exercisable on June 12, 2026, after which 1/48 of the option will become exercisable on the 12th of each month through June 12, 2029. |
Filing footnotes · ownership attribution and instrument terms
F1: The first 25% of the option becomes exercisable on June 12, 2026, after which 1/48 of the option will become exercisable on the 12th of each month through June 12, 2029.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 12, 2025 Filed Jun 16, 2025 20:32 UTC | Humacyte, Inc. HUMA · Entity 6478 | GrantStock Options (right to buy) · Derivative | 80,000 | $0.00 Strike: $2.41 | $0.00 |
DisclosureSEC source: 0001818382-25-000118 · wk-form4_1750105960.xml · derivative · entry 1 Pope Todd · CIK 0001584367 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,000 Underlying: Common Stock · 80,000 shares Expires 2035-06-12 F1 · derivative.exercise_date: The first 25% of the option becomes exercisable on June 12, 2026, after which 1/48 of the option will become exercisable on the 12th of each month through June 12, 2029. Read SEC document |
| June 13, 2024 Filed Jun 17, 2024 20:12 UTC | Humacyte, Inc. HUMA · Entity 6478 | GrantStock Options (right to buy) · Derivative | 50,000 | $0.00 Strike: $7.20 | $0.00 |
DisclosureSEC source: 0001818382-24-000139 · wk-form4_1718655133.xml · derivative · entry 1 Pope Todd · CIK 0001584367 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2034-06-13 F1 · derivative.exercise_date: The first 25% of the option becomes exercisable on June 13, 2025, after which 1/48 of the option will become exercisable on the 13th of each month through June 13, 2028. Read SEC document |
| June 15, 2023 Filed Jun 16, 2023 20:11 UTC | Humacyte, Inc. HUMA · Entity 6478 | GrantStock Options (right to buy) · Derivative | 8,500 | $0.00 Strike: $3.35 | $0.00 |
DisclosureSEC source: 0001818382-23-000089 · wf-form4_168694625802598.xml · derivative · entry 1 Pope Todd · CIK 0001584367 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,500 Underlying: Common Stock · 8,500 shares Expires 2033-06-15 F1 · derivative.exercise_date: The first 25% of the option becomes exercisable on June 15, 2024, after which 1/48 of the option will become exercisable on the 15th of each month through June 15, 2027. Read SEC document |
| June 09, 2022 Filed Jun 13, 2022 20:21 UTC | Humacyte, Inc. HUMA · Entity 6478 | GrantStock Options (right to buy) · Derivative | 8,500 | $0.00 Strike: $4.34 | $0.00 |
DisclosureSEC source: 0001818382-22-000091 · wf-form4_165515169262942.xml · derivative · entry 1 Pope Todd · CIK 0001584367 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,500 Underlying: Common Stock · 8,500 shares Expires 2032-06-09 F1 · derivative.exercise_date: The first 25% of the option becomes exercisable on June 9, 2023, after which 1/48 of the option will become exercisable on the 9th of each month through June 9, 2026. Read SEC document |
| October 13, 2021 Filed Oct 15, 2021 19:37 UTC | Humacyte, Inc. HUMA · Entity 6478 | GrantStock Options (right to buy) · Derivative | 13,000 | $0.00 Strike: $10.03 | $0.00 |
DisclosureSEC source: 0001104659-21-126713 · tm2130120-6_4seq1.xml · derivative · entry 1 Pope Todd · CIK 0001584367 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,000 Underlying: Common Stock · 13,000 shares Expires 2031-10-13 F1 · derivative.exercise_date: The first 25% of the option becomes exercisable on October 13, 2022, after which 1/36 of the option will become exercisable on the 13th of each month through October 13, 2025. Read SEC document |
| May 14, 2019 Filed May 15, 2019 09:00 UTC | ASENSUS SURGICAL, INC. TRXC · Entity 88098 | Exercise / conversionStock Option · Derivative | 71,943 | $0.00 Strike: $1.39 | $0.00 |
DisclosureSEC source: 0001209191-19-029844 · doc4.xml · derivative · entry 2 Pope Todd · CIK 0001584367 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 928,057 Underlying: Common Stock · 71,943 shares Expires 2028-02-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 14, 2019 Filed May 15, 2019 09:00 UTC | ASENSUS SURGICAL, INC. TRXC · Entity 88098 | Exercise / conversionCommon Stock | 71,943 | $1.39 | $100,000.77 |
DisclosureSEC source: 0001209191-19-029844 · doc4.xml · nonDerivative · entry 1 Pope Todd · CIK 0001584367 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 924,359 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 06, 2019 Filed Feb 6, 2019 20:02 UTC | ASENSUS SURGICAL, INC. TRXC · Entity 88098 | GrantRestricted Stock Units · Derivative | 613,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-007895 · doc4.xml · derivative · entry 4 Pope Todd · CIK 0001584367 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 613,000 Underlying: Common Stock · 613,000 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of the Registrant's common stock. F4 · derivative.exercise_date: Forfeiture restrictions will lapse on the restricted stock units in three substantially equal annual installments of 204,334, 204,333 and 204,333 on February 4, 2020, 2021 and 2022 as long as the Reporting Person remains in the employ of the Registrant, subject to acceleration as set forth in the Incentive Plan and the Reporting Person's Employment Agreement with the Company. F4 · derivative.expiration_date: Forfeiture restrictions will lapse on the restricted stock units in three substantially equal annual installments of 204,334, 204,333 and 204,333 on February 4, 2020, 2021 and 2022 as long as the Reporting Person remains in the employ of the Registrant, subject to acceleration as set forth in the Incentive Plan and the Reporting Person's Employment Agreement with the Company. Read SEC document |
| February 06, 2019 Filed Feb 6, 2019 20:02 UTC | ASENSUS SURGICAL, INC. TRXC · Entity 88098 | GrantStock Option · Derivative | 920,000 | $0.00 Strike: $2.47 | $0.00 |
DisclosureSEC source: 0001209191-19-007895 · doc4.xml · derivative · entry 3 Pope Todd · CIK 0001584367 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 920,000 Underlying: Common Stock · 920,000 shares Expires 2029-02-06 F2 · derivative.exercise_date: Vests 25% on the first anniversary of the date of grant and 1/48th of the entire award monthly on the vesting date anniversary for 36 months, subject to acceleration as set forth in the Incentive Plan and the Reporting Person's Employment Agreement with the Company. Read SEC document |
| February 04, 2019 Filed Feb 6, 2019 20:02 UTC | ASENSUS SURGICAL, INC. TRXC · Entity 88098 | Exercise / conversionRestricted Stock Units · Derivative | 40,555 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-007895 · doc4.xml · derivative · entry 8 Pope Todd · CIK 0001584367 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 40,555 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of the Registrant's common stock. F5 · derivative.exercise_date: Forfeiture restrictions will lapse as to 1/3rd of the restricted stock units on February 4 of each of the first three years following the date of grant, as long as the Reporting Person remains in the employ of the Registrant, subject to acceleration as set forth in the Incentive Plan and the Reporting Person's Employment Agreement with the Company. F5 · derivative.expiration_date: Forfeiture restrictions will lapse as to 1/3rd of the restricted stock units on February 4 of each of the first three years following the date of grant, as long as the Reporting Person remains in the employ of the Registrant, subject to acceleration as set forth in the Incentive Plan and the Reporting Person's Employment Agreement with the Company. Read SEC document |
| February 04, 2019 Filed Feb 6, 2019 20:02 UTC | ASENSUS SURGICAL, INC. TRXC · Entity 88098 | Exercise / conversionRestricted Stock Units · Derivative | 52,667 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-007895 · doc4.xml · derivative · entry 7 Pope Todd · CIK 0001584367 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,666 Underlying: Common Stock · 52,667 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of the Registrant's common stock. F5 · derivative.exercise_date: Forfeiture restrictions will lapse as to 1/3rd of the restricted stock units on February 4 of each of the first three years following the date of grant, as long as the Reporting Person remains in the employ of the Registrant, subject to acceleration as set forth in the Incentive Plan and the Reporting Person's Employment Agreement with the Company. F5 · derivative.expiration_date: Forfeiture restrictions will lapse as to 1/3rd of the restricted stock units on February 4 of each of the first three years following the date of grant, as long as the Reporting Person remains in the employ of the Registrant, subject to acceleration as set forth in the Incentive Plan and the Reporting Person's Employment Agreement with the Company. Read SEC document |
| February 04, 2019 Filed Feb 6, 2019 20:02 UTC | ASENSUS SURGICAL, INC. TRXC · Entity 88098 | Exercise / conversionRestricted Stock Units · Derivative | 104,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-007895 · doc4.xml · derivative · entry 6 Pope Todd · CIK 0001584367 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 208,000 Underlying: Common Stock · 104,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of the Registrant's common stock. F5 · derivative.exercise_date: Forfeiture restrictions will lapse as to 1/3rd of the restricted stock units on February 4 of each of the first three years following the date of grant, as long as the Reporting Person remains in the employ of the Registrant, subject to acceleration as set forth in the Incentive Plan and the Reporting Person's Employment Agreement with the Company. F5 · derivative.expiration_date: Forfeiture restrictions will lapse as to 1/3rd of the restricted stock units on February 4 of each of the first three years following the date of grant, as long as the Reporting Person remains in the employ of the Registrant, subject to acceleration as set forth in the Incentive Plan and the Reporting Person's Employment Agreement with the Company. Read SEC document |
| February 04, 2019 Filed Feb 6, 2019 20:02 UTC | ASENSUS SURGICAL, INC. TRXC · Entity 88098 | Exercise / conversionRestricted Stock Units · Derivative | 89,556 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-007895 · doc4.xml · derivative · entry 5 Pope Todd · CIK 0001584367 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 179,111 Underlying: Common Stock · 89,556 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of the Registrant's common stock. F5 · derivative.exercise_date: Forfeiture restrictions will lapse as to 1/3rd of the restricted stock units on February 4 of each of the first three years following the date of grant, as long as the Reporting Person remains in the employ of the Registrant, subject to acceleration as set forth in the Incentive Plan and the Reporting Person's Employment Agreement with the Company. F5 · derivative.expiration_date: Forfeiture restrictions will lapse as to 1/3rd of the restricted stock units on February 4 of each of the first three years following the date of grant, as long as the Reporting Person remains in the employ of the Registrant, subject to acceleration as set forth in the Incentive Plan and the Reporting Person's Employment Agreement with the Company. Read SEC document |
| February 04, 2019 Filed Feb 6, 2019 20:02 UTC | ASENSUS SURGICAL, INC. TRXC · Entity 88098 | Tax withholdingCommon Stock | 86,861 | $2.57 | $223,232.77 |
DisclosureSEC source: 0001209191-19-007895 · doc4.xml · nonDerivative · entry 2 Pope Todd · CIK 0001584367 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 852,416 F1 · kind: This transaction represents the payment of a tax liability on the lapse of forfeiture restrictions on a derivative security and acquisition of the underlying shares. Read SEC document |
| February 04, 2019 Filed Feb 6, 2019 20:02 UTC | ASENSUS SURGICAL, INC. TRXC · Entity 88098 | Exercise / conversionCommon Stock | 286,778 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-007895 · doc4.xml · nonDerivative · entry 1 Pope Todd · CIK 0001584367 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 939,277 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 31, 2018 Filed Nov 2, 2018 20:01 UTC | ASENSUS SURGICAL, INC. TRXC · Entity 88098 | GrantRestricted Stock Units · Derivative | 300,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-057052 · doc4.xml · derivative · entry 1 Pope Todd · CIK 0001584367 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300,000 Underlying: Common Stock · 300,000 shares Expires not disclosed F1 · derivative.exercise_date: Forfeiture restrictions will lapse on the restricted stock units in three equal annual installments of 100,000 on each of July 3, 2019, 2020 and 2021, as long as the reporting person continues to provide services to the Registrant, subject to acceleration as set forth in the Incentive Plan. F1 · derivative.expiration_date: Forfeiture restrictions will lapse on the restricted stock units in three equal annual installments of 100,000 on each of July 3, 2019, 2020 and 2021, as long as the reporting person continues to provide services to the Registrant, subject to acceleration as set forth in the Incentive Plan. Read SEC document |
| July 26, 2018 Filed Jul 30, 2018 20:00 UTC | ASENSUS SURGICAL, INC. TRXC · Entity 88098 | Exercise / conversionStock Option · Derivative | 61,172 | $0.00 Strike: $0.35 | $0.00 |
DisclosureSEC source: 0001209191-18-044487 · doc4.xml · derivative · entry 2 Pope Todd · CIK 0001584367 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 61,172 shares Expires 2022-04-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 26, 2018 Filed Jul 30, 2018 20:00 UTC | ASENSUS SURGICAL, INC. TRXC · Entity 88098 | Exercise / conversionCommon Stock | 61,172 | $0.35 | $21,410.20 |
DisclosureSEC source: 0001209191-18-044487 · doc4.xml · nonDerivative · entry 1 Pope Todd · CIK 0001584367 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 652,499 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 03, 2018 Filed Jul 6, 2018 18:03 UTC | ASENSUS SURGICAL, INC. TRXC · Entity 88098 | Exercise / conversionRestricted Stock Units · Derivative | 500,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-041904 · doc4.xml · derivative · entry 3 Pope Todd · CIK 0001584367 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000,000 Underlying: Common Stock · 500,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Each restricted stock unit represents a right to receive one share of TransEnterix, Inc. (the "Registrant") common stock. F3 · derivative.exercise_date: Forfeiture restrictions will lapse as to 1/3rd of the Restricted Stock Units on each of the first three anniversaries of the date of grant, as long as the Reporting Person remains in the employ of the Registrant. The lapse of forfeiture restrictions may accelerate on certain events as set forth in an employment agreement or the Incentive Plan. F3 · derivative.expiration_date: Forfeiture restrictions will lapse as to 1/3rd of the Restricted Stock Units on each of the first three anniversaries of the date of grant, as long as the Reporting Person remains in the employ of the Registrant. The lapse of forfeiture restrictions may accelerate on certain events as set forth in an employment agreement or the Incentive Plan. Read SEC document |
| July 03, 2018 Filed Jul 6, 2018 18:03 UTC | ASENSUS SURGICAL, INC. TRXC · Entity 88098 | Tax withholdingCommon Stock | 224,745 | $3.84 | $863,020.80 |
DisclosureSEC source: 0001209191-18-041904 · doc4.xml · nonDerivative · entry 2 Pope Todd · CIK 0001584367 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 591,327 F1 · kind: This transaction represents the payment of a tax liability on the lapse of forfeiture restrictions on a derivative security and acquisition of the underlying shares. Read SEC document |
| July 03, 2018 Filed Jul 6, 2018 18:03 UTC | ASENSUS SURGICAL, INC. TRXC · Entity 88098 | Exercise / conversionCommon Stock | 500,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-041904 · doc4.xml · nonDerivative · entry 1 Pope Todd · CIK 0001584367 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 816,072 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 26, 2018 Filed Jun 27, 2018 20:00 UTC | ASENSUS SURGICAL, INC. TRXC · Entity 88098 | Exercise / conversionStock Option · Derivative | 160,086 | $0.00 Strike: $0.35 | $0.00 |
DisclosureSEC source: 0001209191-18-039730 · doc4.xml · derivative · entry 9 Pope Todd · CIK 0001584367 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,172 Underlying: Common Stock · 160,086 shares Expires 2022-04-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The identified transactions set forth on this Form 4 were made pursuant to a Rule 10b5-1(c) sales plan executed by the reporting person on August 9, 2017, as amended on September 20, 2017. Read SEC document |
| June 26, 2018 Filed Jun 27, 2018 20:00 UTC | ASENSUS SURGICAL, INC. TRXC · Entity 88098 | SaleCommon Stock | 160,086 | $5.35 | $856,460.10 |
DisclosureSEC source: 0001209191-18-039730 · doc4.xml · nonDerivative · entry 6 Pope Todd · CIK 0001584367 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 316,072 F1 · security: The identified transactions set forth on this Form 4 were made pursuant to a Rule 10b5-1(c) sales plan executed by the reporting person on August 9, 2017, as amended on September 20, 2017. F2 · security: Following the sales on June 25, 2018 and June 26, 2018, the reporting person continues to beneficially own 316,072 shares of the company's common stock. The reporting person also holds stock options to acquire 4,035,262 shares of common stock, of which approximately 47% are vested, and restricted stock units representing an additional 2,226,555 shares of common stock subject to forfeiture restrictions. F2 · balance_after: Following the sales on June 25, 2018 and June 26, 2018, the reporting person continues to beneficially own 316,072 shares of the company's common stock. The reporting person also holds stock options to acquire 4,035,262 shares of common stock, of which approximately 47% are vested, and restricted stock units representing an additional 2,226,555 shares of common stock subject to forfeiture restrictions. Read SEC document |
| June 26, 2018 Filed Jun 27, 2018 20:00 UTC | ASENSUS SURGICAL, INC. TRXC · Entity 88098 | Exercise / conversionCommon Stock | 160,086 | $0.35 | $56,030.10 |
DisclosureSEC source: 0001209191-18-039730 · doc4.xml · nonDerivative · entry 5 Pope Todd · CIK 0001584367 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 476,158 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The identified transactions set forth on this Form 4 were made pursuant to a Rule 10b5-1(c) sales plan executed by the reporting person on August 9, 2017, as amended on September 20, 2017. Read SEC document |
| June 25, 2018 Filed Jun 27, 2018 20:00 UTC | ASENSUS SURGICAL, INC. TRXC · Entity 88098 | Exercise / conversionStock Option · Derivative | 61,445 | $0.00 Strike: $0.35 | $0.00 |
DisclosureSEC source: 0001209191-18-039730 · doc4.xml · derivative · entry 8 Pope Todd · CIK 0001584367 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 221,258 Underlying: Common Stock · 61,445 shares Expires 2022-04-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The identified transactions set forth on this Form 4 were made pursuant to a Rule 10b5-1(c) sales plan executed by the reporting person on August 9, 2017, as amended on September 20, 2017. Read SEC document |
| June 25, 2018 Filed Jun 27, 2018 20:00 UTC | ASENSUS SURGICAL, INC. TRXC · Entity 88098 | Exercise / conversionStock Option · Derivative | 138,555 | $0.00 Strike: $0.35 | $0.00 |
DisclosureSEC source: 0001209191-18-039730 · doc4.xml · derivative · entry 7 Pope Todd · CIK 0001584367 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 138,555 shares Expires 2022-04-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The identified transactions set forth on this Form 4 were made pursuant to a Rule 10b5-1(c) sales plan executed by the reporting person on August 9, 2017, as amended on September 20, 2017. Read SEC document |
| June 25, 2018 Filed Jun 27, 2018 20:00 UTC | ASENSUS SURGICAL, INC. TRXC · Entity 88098 | SaleCommon Stock | 100,000 | $4.85 | $485,000.00 |
DisclosureSEC source: 0001209191-18-039730 · doc4.xml · nonDerivative · entry 4 Pope Todd · CIK 0001584367 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 316,072 F1 · security: The identified transactions set forth on this Form 4 were made pursuant to a Rule 10b5-1(c) sales plan executed by the reporting person on August 9, 2017, as amended on September 20, 2017. Read SEC document |
| June 25, 2018 Filed Jun 27, 2018 20:00 UTC | ASENSUS SURGICAL, INC. TRXC · Entity 88098 | Exercise / conversionCommon Stock | 61,445 | $0.35 | $21,505.75 |
DisclosureSEC source: 0001209191-18-039730 · doc4.xml · nonDerivative · entry 3 Pope Todd · CIK 0001584367 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 416,072 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The identified transactions set forth on this Form 4 were made pursuant to a Rule 10b5-1(c) sales plan executed by the reporting person on August 9, 2017, as amended on September 20, 2017. Read SEC document |
| June 25, 2018 Filed Jun 27, 2018 20:00 UTC | ASENSUS SURGICAL, INC. TRXC · Entity 88098 | SaleCommon Stock | 100,000 | $4.35 | $435,000.00 |
DisclosureSEC source: 0001209191-18-039730 · doc4.xml · nonDerivative · entry 2 Pope Todd · CIK 0001584367 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 354,627 F1 · security: The identified transactions set forth on this Form 4 were made pursuant to a Rule 10b5-1(c) sales plan executed by the reporting person on August 9, 2017, as amended on September 20, 2017. Read SEC document |
| June 25, 2018 Filed Jun 27, 2018 20:00 UTC | ASENSUS SURGICAL, INC. TRXC · Entity 88098 | Exercise / conversionCommon Stock | 138,555 | $0.35 | $48,494.25 |
DisclosureSEC source: 0001209191-18-039730 · doc4.xml · nonDerivative · entry 1 Pope Todd · CIK 0001584367 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 454,627 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The identified transactions set forth on this Form 4 were made pursuant to a Rule 10b5-1(c) sales plan executed by the reporting person on August 9, 2017, as amended on September 20, 2017. Read SEC document |
| February 15, 2018 Filed Feb 16, 2018 18:05 UTC | ASENSUS SURGICAL, INC. TRXC · Entity 88098 | GrantRestricted Stock Units · Derivative | 268,667 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-010969 · doc4.xml · derivative · entry 2 Pope Todd · CIK 0001584367 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 268,667 Underlying: Common Stock · 268,667 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of the Registrant's common stock. F4 · derivative.exercise_date: Forfeiture restrictions will lapse on the restricted stock units in three annual installments of one-third of the award (89,555, 89,556 and 89,556) on each of February 4, 2019, 2020 and 2021, respectively, as long as the Reporting Person remains in the employ of the Registrant, subject to acceleration as set forth in the Incentive Plan. F4 · derivative.expiration_date: Forfeiture restrictions will lapse on the restricted stock units in three annual installments of one-third of the award (89,555, 89,556 and 89,556) on each of February 4, 2019, 2020 and 2021, respectively, as long as the Reporting Person remains in the employ of the Registrant, subject to acceleration as set forth in the Incentive Plan. Read SEC document |
| February 15, 2018 Filed Feb 16, 2018 18:05 UTC | ASENSUS SURGICAL, INC. TRXC · Entity 88098 | OtherStock Options · Derivative | 403,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-010969 · doc4.xml · derivative · entry 1 Pope Todd · CIK 0001584367 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000,000 Underlying: Common Stock · 403,000 shares Expires 2028-02-07 F1 · derivative.exercise_price: A portion of a stock option grant made on February 7, 2018 was rescinded by the Compensation Committee of the Board of Directors, as the original stock option grant inadvertantly exceeded (by 403,000 stock options) the 1,000,000 annual share limitation available for 2018 under the Company's Amended and Restated Incentive Compensation Plan, as amended (the "Incentive Plan"). The terms of the remainder of the stock option grant, now to acquire 1,000,000 shares of common stock, remain in full force and effect. F1 · kind: A portion of a stock option grant made on February 7, 2018 was rescinded by the Compensation Committee of the Board of Directors, as the original stock option grant inadvertantly exceeded (by 403,000 stock options) the 1,000,000 annual share limitation available for 2018 under the Company's Amended and Restated Incentive Compensation Plan, as amended (the "Incentive Plan"). The terms of the remainder of the stock option grant, now to acquire 1,000,000 shares of common stock, remain in full force and effect. F1 · shares: A portion of a stock option grant made on February 7, 2018 was rescinded by the Compensation Committee of the Board of Directors, as the original stock option grant inadvertantly exceeded (by 403,000 stock options) the 1,000,000 annual share limitation available for 2018 under the Company's Amended and Restated Incentive Compensation Plan, as amended (the "Incentive Plan"). The terms of the remainder of the stock option grant, now to acquire 1,000,000 shares of common stock, remain in full force and effect. F2 · derivative.exercise_date: Vests 25% on the first anniversary of the date of grant and 1/48th of the entire award monthly on the vesting date anniversary for 36 months, subject to acceleration as set forth in the Incentive Plan. F1 · derivative.underlying_shares: A portion of a stock option grant made on February 7, 2018 was rescinded by the Compensation Committee of the Board of Directors, as the original stock option grant inadvertantly exceeded (by 403,000 stock options) the 1,000,000 annual share limitation available for 2018 under the Company's Amended and Restated Incentive Compensation Plan, as amended (the "Incentive Plan"). The terms of the remainder of the stock option grant, now to acquire 1,000,000 shares of common stock, remain in full force and effect. F1 · balance_after: A portion of a stock option grant made on February 7, 2018 was rescinded by the Compensation Committee of the Board of Directors, as the original stock option grant inadvertantly exceeded (by 403,000 stock options) the 1,000,000 annual share limitation available for 2018 under the Company's Amended and Restated Incentive Compensation Plan, as amended (the "Incentive Plan"). The terms of the remainder of the stock option grant, now to acquire 1,000,000 shares of common stock, remain in full force and effect. Read SEC document |
| February 07, 2018 Filed Feb 7, 2018 20:06 UTC | ASENSUS SURGICAL, INC. TRXC · Entity 88098 | GrantRestricted Stock Units · Derivative | 312,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-008272 · doc4.xml · derivative · entry 4 Pope Todd · CIK 0001584367 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 312,000 Underlying: Common Stock · 312,000 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of the Registrant's common stock. F4 · derivative.exercise_date: Forfeiture restrictions will lapse on the restricted stock units in three equal annual installments of 104,000 on each of February 4, 2019, 2020 and 2021, as long as the Reporting Person remains in the employ of the Registrant, subject to acceleration as set forth in the Incentive Plan. F4 · derivative.expiration_date: Forfeiture restrictions will lapse on the restricted stock units in three equal annual installments of 104,000 on each of February 4, 2019, 2020 and 2021, as long as the Reporting Person remains in the employ of the Registrant, subject to acceleration as set forth in the Incentive Plan. Read SEC document |
| February 07, 2018 Filed Feb 7, 2018 20:06 UTC | ASENSUS SURGICAL, INC. TRXC · Entity 88098 | GrantStock Option · Derivative | 1,403,000 | $0.00 Strike: $1.39 | $0.00 |
DisclosureSEC source: 0001209191-18-008272 · doc4.xml · derivative · entry 3 Pope Todd · CIK 0001584367 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,403,000 Underlying: Common Stock · 1,403,000 shares Expires 2028-02-07 F2 · derivative.exercise_date: Vests 25% on the first anniversary of the date of grant and 1/48th of the entire award monthly on the vesting date anniversary for 36 months, subject to acceleration as set forth in the Incentive Plan. Read SEC document |
| February 05, 2018 Filed Feb 7, 2018 20:06 UTC | ASENSUS SURGICAL, INC. TRXC · Entity 88098 | Exercise / conversionRestricted Stock Units · Derivative | 52,667 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-008272 · doc4.xml · derivative · entry 7 Pope Todd · CIK 0001584367 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,333 Underlying: Common Stock · 52,667 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of the Registrant's common stock. F5 · derivative.exercise_date: Forfeiture restrictions will lapse as to 1/3rd of the restricted stock units on February 4 of each of the first three years following the date of grant, as long as the Reporting Person remains in the employ of the Registrant, subject to acceleration as set forth in the Incentive Plan. F5 · derivative.expiration_date: Forfeiture restrictions will lapse as to 1/3rd of the restricted stock units on February 4 of each of the first three years following the date of grant, as long as the Reporting Person remains in the employ of the Registrant, subject to acceleration as set forth in the Incentive Plan. Read SEC document |
| February 05, 2018 Filed Feb 7, 2018 20:06 UTC | ASENSUS SURGICAL, INC. TRXC · Entity 88098 | Exercise / conversionRestricted Stock Units · Derivative | 33,333 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-008272 · doc4.xml · derivative · entry 6 Pope Todd · CIK 0001584367 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 33,333 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of the Registrant's common stock. F5 · derivative.exercise_date: Forfeiture restrictions will lapse as to 1/3rd of the restricted stock units on February 4 of each of the first three years following the date of grant, as long as the Reporting Person remains in the employ of the Registrant, subject to acceleration as set forth in the Incentive Plan. F5 · derivative.expiration_date: Forfeiture restrictions will lapse as to 1/3rd of the restricted stock units on February 4 of each of the first three years following the date of grant, as long as the Reporting Person remains in the employ of the Registrant, subject to acceleration as set forth in the Incentive Plan. Read SEC document |
| February 05, 2018 Filed Feb 7, 2018 20:06 UTC | ASENSUS SURGICAL, INC. TRXC · Entity 88098 | Exercise / conversionRestricted Stock Units · Derivative | 40,556 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-008272 · doc4.xml · derivative · entry 5 Pope Todd · CIK 0001584367 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,555 Underlying: Common Stock · 40,556 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of the Registrant's common stock. F5 · derivative.exercise_date: Forfeiture restrictions will lapse as to 1/3rd of the restricted stock units on February 4 of each of the first three years following the date of grant, as long as the Reporting Person remains in the employ of the Registrant, subject to acceleration as set forth in the Incentive Plan. F5 · derivative.expiration_date: Forfeiture restrictions will lapse as to 1/3rd of the restricted stock units on February 4 of each of the first three years following the date of grant, as long as the Reporting Person remains in the employ of the Registrant, subject to acceleration as set forth in the Incentive Plan. Read SEC document |
| February 05, 2018 Filed Feb 7, 2018 20:06 UTC | ASENSUS SURGICAL, INC. TRXC · Entity 88098 | Tax withholdingCommon Stock | 40,484 | $1.53 | $61,940.52 |
DisclosureSEC source: 0001209191-18-008272 · doc4.xml · nonDerivative · entry 2 Pope Todd · CIK 0001584367 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 316,072 F1 · kind: This transaction represents the payment of a tax liability on the lapse of forfeiture restrictions on a derivative security and acquisition of the underlying shares. Read SEC document |
| February 05, 2018 Filed Feb 7, 2018 20:06 UTC | ASENSUS SURGICAL, INC. TRXC · Entity 88098 | Exercise / conversionCommon Stock | 126,556 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-008272 · doc4.xml · nonDerivative · entry 1 Pope Todd · CIK 0001584367 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 356,556 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 02, 2017 Filed Nov 2, 2017 13:35 UTC | ASENSUS SURGICAL, INC. TRXC · Entity 88098 | Exercise / conversionIncentive Stock Option · Derivative | 80,000 | $0.00 Strike: $0.35 | $0.00 |
DisclosureSEC source: 0001209191-17-058752 · doc4.xml · derivative · entry 2 Pope Todd · CIK 0001584367 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 282,703 Underlying: Common Stock · 80,000 shares Expires 2022-04-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 02, 2017 Filed Nov 2, 2017 13:35 UTC | ASENSUS SURGICAL, INC. TRXC · Entity 88098 | Exercise / conversionCommon Stock | 80,000 | $0.35 | $28,000.00 |
DisclosureSEC source: 0001209191-17-058752 · doc4.xml · nonDerivative · entry 1 Pope Todd · CIK 0001584367 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 230,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The reporting person exercised an incentive stock option. F1 · balance_after: The reporting person exercised an incentive stock option. Read SEC document |
| October 18, 2017 Filed Oct 20, 2017 17:23 UTC | ASENSUS SURGICAL, INC. TRXC · Entity 88098 | Exercise / conversionStock Option · Derivative | 287,356 | $0.00 Strike: $0.35 | $0.00 |
DisclosureSEC source: 0001209191-17-057667 · doc4.xml · derivative · entry 5 Pope Todd · CIK 0001584367 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,555 Underlying: Common Stock · 287,356 shares Expires 2022-04-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The identified transactions set forth on this Form 4 were made pursuant to a Rule 10b5-1(c) sales plan executed by the reporting person on August 9, 2017, as amended. Read SEC document |
| October 18, 2017 Filed Oct 20, 2017 17:23 UTC | ASENSUS SURGICAL, INC. TRXC · Entity 88098 | Exercise / conversionStock Option · Derivative | 95,335 | $0.00 Strike: $0.35 | $0.00 |
DisclosureSEC source: 0001209191-17-057667 · doc4.xml · derivative · entry 4 Pope Todd · CIK 0001584367 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 95,335 shares Expires 2019-12-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The identified transactions set forth on this Form 4 were made pursuant to a Rule 10b5-1(c) sales plan executed by the reporting person on August 9, 2017, as amended. Read SEC document |
| October 18, 2017 Filed Oct 20, 2017 17:23 UTC | ASENSUS SURGICAL, INC. TRXC · Entity 88098 | SaleCommon Stock | 600,000 | $3.68 | $2,208,000.00 |
DisclosureSEC source: 0001209191-17-057667 · doc4.xml · nonDerivative · entry 3 Pope Todd · CIK 0001584367 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 F1 · security: The identified transactions set forth on this Form 4 were made pursuant to a Rule 10b5-1(c) sales plan executed by the reporting person on August 9, 2017, as amended. F2 · price: The sale price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.46 to $4.23 inclusive. The reporting person undertakes to provide to TransEnterix, Inc., any security holder of TransEnterix, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document |
| October 18, 2017 Filed Oct 20, 2017 17:23 UTC | ASENSUS SURGICAL, INC. TRXC · Entity 88098 | Exercise / conversionCommon Stock | 287,356 | $0.35 | $100,574.60 |
DisclosureSEC source: 0001209191-17-057667 · doc4.xml · nonDerivative · entry 2 Pope Todd · CIK 0001584367 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 750,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The identified transactions set forth on this Form 4 were made pursuant to a Rule 10b5-1(c) sales plan executed by the reporting person on August 9, 2017, as amended. Read SEC document |
| October 18, 2017 Filed Oct 20, 2017 17:23 UTC | ASENSUS SURGICAL, INC. TRXC · Entity 88098 | Exercise / conversionCommon Stock | 95,335 | $0.35 | $33,367.25 |
DisclosureSEC source: 0001209191-17-057667 · doc4.xml · nonDerivative · entry 1 Pope Todd · CIK 0001584367 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 462,644 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The identified transactions set forth on this Form 4 were made pursuant to a Rule 10b5-1(c) sales plan executed by the reporting person on August 9, 2017, as amended. Read SEC document |
| October 18, 2017 Filed Oct 20, 2017 17:18 UTC | ASENSUS SURGICAL, INC. TRXC · Entity 88098 | Exercise / conversionIncentive Stock Option · Derivative | 140,649 | $0.00 Strike: $0.35 | $0.00 |
DisclosureSEC source: 0001209191-17-057664 · doc4.xml · derivative · entry 4 Pope Todd · CIK 0001584367 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 362,703 Underlying: Common Stock · 140,649 shares Expires 2022-04-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 18, 2017 Filed Oct 20, 2017 17:18 UTC | ASENSUS SURGICAL, INC. TRXC · Entity 88098 | Exercise / conversionIncentive Stock Option · Derivative | 9,351 | $0.00 Strike: $0.35 | $0.00 |
DisclosureSEC source: 0001209191-17-057664 · doc4.xml · derivative · entry 3 Pope Todd · CIK 0001584367 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,351 shares Expires 2019-12-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 18, 2017 Filed Oct 20, 2017 17:18 UTC | ASENSUS SURGICAL, INC. TRXC · Entity 88098 | Exercise / conversionCommon Stock | 140,649 | $0.35 | $49,227.15 |
DisclosureSEC source: 0001209191-17-057664 · doc4.xml · nonDerivative · entry 2 Pope Todd · CIK 0001584367 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 367,309 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The reporting person exercised an incentive stock option. F1 · balance_after: The reporting person exercised an incentive stock option. Read SEC document |
| October 18, 2017 Filed Oct 20, 2017 17:18 UTC | ASENSUS SURGICAL, INC. TRXC · Entity 88098 | Exercise / conversionCommon Stock | 9,351 | $0.35 | $3,272.85 |
DisclosureSEC source: 0001209191-17-057664 · doc4.xml · nonDerivative · entry 1 Pope Todd · CIK 0001584367 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 226,660 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The reporting person exercised an incentive stock option. F1 · balance_after: The reporting person exercised an incentive stock option. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.